SCHEMBL30452950

SCHEMBL30452950

CCN(CC)CCS(=O)(=O)Nc1cccc(-c2cnc(N)c(OCc3c(F)ccc(F)c3Cl)n2)c1

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TYRO3 Q06418 3/20 0.41
PIK3CD O00329 8/20 0.39
PIK3CA P42336 8/20 0.39
PIK3CG P48736 8/20 0.39
PIK3CB P42338 7/20 0.39
CSF1R P07333 1/20 0.39
ATR Q13535 3/20 0.38
TP53 P04637 2/20 0.35
NPC1 O15118 2/20 0.35
JAK2 O60674 1/20 0.35
RAB9A P51151 1/20 0.35
KDM1A O60341 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL488712 1.00 TYRO3 (0.41) TYRO3PIK3CDPIK3CAPIK3CGPIK3CB
SCHEMBL30452487 0.92 TYRO3 (0.42) TYRO3PIK3CDPIK3CAPIK3CGPIK3CB
SCHEMBL488225 0.92 TYRO3 (0.42) TYRO3PIK3CDPIK3CAPIK3CGPIK3CB
SCHEMBL30452448 0.90 SGK1 (0.38) PIK3CDPIK3CAPIK3CGPIK3CBCSF1R
SCHEMBL488075 0.90 SGK1 (0.38) PIK3CDPIK3CAPIK3CGPIK3CBCSF1R
SCHEMBL487815 0.86 MET (0.40) JAK2
SCHEMBL30453026 0.86 MET (0.40) JAK2
SCHEMBL488736 0.84 TYRO3 (0.42) TYRO3PIK3CDPIK3CAPIK3CGPIK3CB
SCHEMBL487930 0.84 MAP4K4 (0.45) TYRO3PIK3CDPIK3CAPIK3CGPIK3CB
SCHEMBL30454893 0.84 MAP4K4 (0.45) TYRO3PIK3CDPIK3CAPIK3CGPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4599890-A2 SUNITINIB FOR PREVENTING AND/OR TREATING AMYOTROPHIC LATERAL SCLEROSIS Kyoto University (JP) 2025-08-13 EP disclosed
CN-113181362-B Medicament for preventing and/or treating amyotrophic lateral sclerosis 国立大学法人京都大学 2023-06-13 CN disclosed